Merck, Others Beat Warning Claims In Diabetes Drug MDL
Drugmakers including Merck defeated state law claims in multidistrict litigation accusing the companies of failing to warn patients of pancreas problems from Type 2 diabetes drugs when a California federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article